Categories: News

INFINITT North America Announces Collaboration with Brainreader A/S to Market Neuro AI for Brain Structure Analysis

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

INFINITT North America and Brainreader A/S announced today a wide ranging and unique partnership to expand and deepen the use of Brainreader’s FDA cleared Neuroreader software. Neuroreader Report analyzes an MRI sequence to determine whether brain structures are abnormal and to what extent. It visualizes and quantifies 45 individual brain structures in less than ten minutes after Magnetic Resonance Imaging.

PHILLIPSBURG, N.J., June 9, 2022 /PRNewswire-PRWeb/ — INFINITT North America and Brainreader A/S announced today a wide ranging and unique partnership to expand and deepen the use of Brainreader’s FDA cleared Neuroreader software. Neuroreader Report analyzes an MRI sequence to determine whether brain structures are abnormal and to what extent. It visualizes and quantifies 45 individual brain structures in less than ten minutes after Magnetic Resonance Imaging.

“We are very excited about the INFINITT/Brianreader partnership,” said Brainreader CEO Mads Fiig. “This relationship combines forward looking science with an extremely useful tool for clinicians. Omar Rocha, our U.S. President, has been instrumental in building this wide embrace of the INFINITT customer base.”

INFINITT North America, an award-winning developer of enterprise imaging solutions for healthcare, will utilize Neuroreader throughout its U.S. operations, focusing on Hippocampal lobe volume, atrophies and trends as well as applying data from Brainreader’s advanced diversified normative datasets. Brainreader’s expanding AI technology brings objectivity into clinical practice, detecting anomalous brain patterns, and is a proven guide for clinical decision making.

“AI and rigorously applied clinical science have resulted in new uses for brain data as a clinical tool, promoting earlier treatments, and more accurate diagnoses”, said David Smarro, INFINITT N.A. President and CEO. “Neuroreader speeds up the process, increases accuracy and will improve clinical outcomes.”

“INFINITT’s large North American customer base provides an opportunity for both companies to uniquely contribute” said Omar Rocha, U.S. Brainreader President, “to improving doctors’ speed, accuracy, and depth of understanding as well as providing actionable aid in diagnosis and treatment.”

About INFINITT North America

INFINITT North America is the North American business unit of INFINITT Healthcare, a global company with more than 6500 installations in 55 countries. INFINITT’s enterprise imaging solutions include INFINITT Healthcare Platform (VNA), RIS, PACS, Mammography PACS, Cardiology Suite, Digital Pathology PACS, RT PACS, Dental PACS, Ophthalmology PACS, an AI Integration Platform and an Advanced Visualization software platform. For more information, call 877-387-6960 or visit infinittna.com.

Media Contact

Deborah Reed, INFINITT North America, 1 877-387-6960, info@infinittna.com

Twitter, LinkedIn

SOURCE INFINITT North America

Staff

Recent Posts

TriSalus Life Sciences to Host Second Quarter 2025 Financial Results Conference Call

Conference Call and Webcast Scheduled for Tuesday August 12, 2025 at 4:30 PMWESTMINSTER, Colo.--(BUSINESS WIRE)--TriSalus…

9 hours ago

GLOBO Language Solutions Honored as Silver Stevie® Award Winner for Technology Breakthrough of the Year − Artificial Intelligence

PHILADELPHIA, July 29, 2025 /PRNewswire/ -- GLOBO Language Solutions, the leading B2B provider of interpreting and…

9 hours ago

AI Just Got a Green Light from the White House–Here’s What That Means for Healthcare Stocks

Equity Insider News CommentaryIssued on behalf of Avant Technologies Inc. VANCOUVER, BC, July 29, 2025…

9 hours ago

Rapid Expansion and Innovation Drive $36 Billion Global Point-of-Care Diagnostics Market, Says New Kalorama Report

ARLINGTON, Va., July 29, 2025 /PRNewswire/ -- A new report from Kalorama Information reveals that the…

9 hours ago

Revolutionizing Patient Care Through Advanced Brain Monitoring and Generative AI

PHILADELPHIA, July 29, 2025 /PRNewswire/ -- In a bold step toward transforming neurocritical care, Moberg…

9 hours ago

PRC Enhances VoicesAI™ with Meta’s LLaMA to Deliver Predictive Comment Intelligence for Healthcare

Upgraded VoicesAI™ solution built with LLaMA—Meta's advanced open-source language model—delivers faster, smarter comment analysis and…

9 hours ago